Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor
- 15 September 2001
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 358 (3) , 673-9
- https://doi.org/10.1042/0264-6021:3580673
Abstract
Urokinase (uPA) has the striking ability to cleave its receptor, uPAR, thereby inactivating the binding potential of this molecule. Here we demonstrate that the glycosylphosphatidylinositol (GPI) anchor of uPAR, which is attached to the third domain, is an important determinant in governing this reaction, even though the actual cleavage occurs between the first and second domains. Purified full-length GPI-anchored uPAR (GPI-uPAR) proved much more susceptible to uPA-mediated cleavage than recombinant truncated soluble uPAR (suPAR), which lacks the glycolipid anchor. This was not a general difference in proteolytic susceptibility since GPI-uPAR and suPAR were cleaved with equal efficiency by plasmin. Since the amino acid sequences of GPI-uPAR and suPAR are identical except for the C-terminal truncation, the different cleavage patterns suggest that the two uPAR variants differ in the conformation or the flexibility of the linker region between domains 1 and 2. This was supported by the fact that an antibody to the peptide AVTYSRSRYLE, amino acids 84-94 in the linker region, recognizes GPI-uPAR but not suPAR. This difference in the linker region is thus caused by a difference in a remote hydrophobic region. In accordance with this model, when the hydrophobic lipid moiety was removed from the glycolipid anchor by phospholipase C, low concentrations of uPA could no longer cleave the modified GPI-uPAR and the reactivity to the peptide antibody was greatly decreased. Naturally occurring suPAR, purified from plasma, was found to have a similar resistance to uPA cleavage as phospholipase C-treated GPI-uPAR and recombinant suPAR.Keywords
This publication has 43 references indexed in Scilit:
- Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.1999
- A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Journal of Clinical Investigation, 1993
- Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteinsJournal of Biological Chemistry, 1993
- Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.Journal of Biological Chemistry, 1992
- Identification and characterization of the murine cell surface receptor for the urokinase‐type plasminogen activatorEuropean Journal of Biochemistry, 1992
- Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptorFEBS Letters, 1991
- The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.Journal of Biological Chemistry, 1991
- Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositolJournal of Biological Chemistry, 1991
- The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.Journal of Biological Chemistry, 1990
- The glycosyl-phosphatidylinositol anchor of membrane proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1989